These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 31588710)

  • 1. Novel small molecule protein kinase CK2 inhibitors exert potent antitumor effects on T98G and SEGA cells in vitro.
    Pucko E; Ostrowski R; Matyja E
    Folia Neuropathol; 2019; 57(3):239-248. PubMed ID: 31588710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and mechanism of anti-tumor action of new potential CK2 inhibitors toward glioblastoma cells.
    Kaminska B; Ellert-Miklaszewska A; Oberbek A; Wisniewski P; Kaza B; Makowska M; Bretner M; Kazimierczuk Z
    Int J Oncol; 2009 Nov; 35(5):1091-100. PubMed ID: 19787263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent Antitumour Effects of Novel Pentabromobenzylisothioureas Studied on Human Glial-derived Tumour Cell Lines.
    Pucko E; Matyja E; Koronkiewicz M; Ostrowski RP; Kazimierczuk Z
    Anticancer Res; 2018 May; 38(5):2691-2705. PubMed ID: 29715089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The selectivity of inhibitors of protein kinase CK2: an update.
    Pagano MA; Bain J; Kazimierczuk Z; Sarno S; Ruzzene M; Di Maira G; Elliott M; Orzeszko A; Cozza G; Meggio F; Pinna LA
    Biochem J; 2008 Nov; 415(3):353-65. PubMed ID: 18588507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DMAT, an inhibitor of protein kinase CK2 induces reactive oxygen species and DNA double strand breaks.
    Schneider CC; Hessenauer A; Götz C; Montenarh M
    Oncol Rep; 2009 Jun; 21(6):1593-7. PubMed ID: 19424641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and exploitation of CK2 inhibitors.
    Sarno S; Ruzzene M; Frascella P; Pagano MA; Meggio F; Zambon A; Mazzorana M; Di Maira G; Lucchini V; Pinna LA
    Mol Cell Biochem; 2005 Jun; 274(1-2):69-76. PubMed ID: 16335530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-Dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole: a novel powerful and selective inhibitor of protein kinase CK2.
    Pagano MA; Meggio F; Ruzzene M; Andrzejewska M; Kazimierczuk Z; Pinna LA
    Biochem Biophys Res Commun; 2004 Sep; 321(4):1040-4. PubMed ID: 15358133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An unbiased evaluation of CK2 inhibitors by chemoproteomics: characterization of inhibitor effects on CK2 and identification of novel inhibitor targets.
    Duncan JS; Gyenis L; Lenehan J; Bretner M; Graves LM; Haystead TA; Litchfield DW
    Mol Cell Proteomics; 2008 Jun; 7(6):1077-88. PubMed ID: 18258654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quinone reductase 2 is an adventitious target of protein kinase CK2 inhibitors TBBz (TBI) and DMAT.
    Leung KK; Shilton BH
    Biochemistry; 2015 Jan; 54(1):47-59. PubMed ID: 25379648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, in vitro antiproliferative activity and kinase profile of new benzimidazole and benzotriazole derivatives.
    Chojnacki K; Wińska P; Skierka K; Wielechowska M; Bretner M
    Bioorg Chem; 2017 Jun; 72():1-10. PubMed ID: 28340404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of experimental HCC growth in mice by use of the kinase inhibitor DMAT.
    Sass G; Klinger N; Sirma H; Hashemolhosseini S; Hellerbrand C; Neureiter D; Wege H; Ocker M; Tiegs G
    Int J Oncol; 2011 Aug; 39(2):433-42. PubMed ID: 21567083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic anti-leukemic effects of CK2 inhibitors and pentabromobenzylisothioureas in vitro.
    Koronkiewicz M; Chilmonczyk Z; Kazimierczuk Z
    Anticancer Res; 2013 Nov; 33(11):4891-9. PubMed ID: 24222126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2.
    Cozza G; Mazzorana M; Papinutto E; Bain J; Elliott M; di Maira G; Gianoncelli A; Pagano MA; Sarno S; Ruzzene M; Battistutta R; Meggio F; Moro S; Zagotto G; Pinna LA
    Biochem J; 2009 Jul; 421(3):387-95. PubMed ID: 19432557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-neoplastic effect of protein kinase CK2 inhibitor, 2-dimethylamino-4,5,6,7-tetrabromobenzimidazole (DMAT), on growth and hormonal activity of human adrenocortical carcinoma cell line (H295R) in vitro.
    Lawnicka H; Kowalewicz-Kulbat M; Sicinska P; Kazimierczuk Z; Grieb P; Stepien H
    Cell Tissue Res; 2010 May; 340(2):371-9. PubMed ID: 20383646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selectivity analysis of protein kinase CK2 inhibitors DMAT, TBB and resorufin in cisplatin-induced stress responses.
    Fritz G; Issinger OG; Olsen BB
    Int J Oncol; 2009 Nov; 35(5):1151-7. PubMed ID: 19787270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multitarget Anticancer Agents Based on Histone Deacetylase and Protein Kinase CK2 inhibitors.
    Martínez R; Geronimo BD; Pastor M; Zapico JM; Coderch C; Panchuk R; Skorokhyd N; Maslyk M; Ramos A; de Pascual-Teresa B
    Molecules; 2020 Mar; 25(7):. PubMed ID: 32218358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Casein kinase-2 induces p53-dependent cell cycle arrest and sensitizes glioblastoma cells to tumor necrosis factor (TNFα)-induced apoptosis through SIRT1 inhibition.
    Dixit D; Sharma V; Ghosh S; Mehta VS; Sen E
    Cell Death Dis; 2012 Feb; 3(2):e271. PubMed ID: 22318540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New inhibitors of protein kinase CK2, analogues of benzimidazole and benzotriazole.
    Bretner M; Najda-Bernatowicz A; Łebska M; Muszyńska G; Kilanowicz A; Sapota A
    Mol Cell Biochem; 2008 Sep; 316(1-2):87-9. PubMed ID: 18548199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CK2 inhibition induced PDK4-AMPK axis regulates metabolic adaptation and survival responses in glioma.
    Dixit D; Ahmad F; Ghildiyal R; Joshi SD; Sen E
    Exp Cell Res; 2016 May; 344(1):132-142. PubMed ID: 27001465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Casein kinase-II inhibition promotes retinal ganglion cell survival and axonal regeneration.
    Cen LP; Liu YF; Ng TK; Luo JM; van Rooijen N; Zhang M; Pang CP; Cui Q
    Exp Eye Res; 2018 Dec; 177():153-159. PubMed ID: 30118655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.